Revenue Increases 568% Year–over–Year and 78% Sequentially to $4.94 Million
Q3 2025 Net Income Reaches $65.59 Million Driven by Ethereum Accumulation
Read more »
Revenue Increases 568% Year–over–Year and 78% Sequentially to $4.94 Million
Q3 2025 Net Income Reaches $65.59 Million Driven by Ethereum Accumulation
Read more »
استمرار التوسع الدولي كمحرك رئيسي [...] Read more »
Revenue growth of 12.4%, and 47% in constant currency for Q1 2025 over Q1 2024
Achieved $0.8 million in Net Profit in Q1 2025
Dollar pegged revenue increased [...] Read more »
JERUSALEM, May 09, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business updates for [...] Read more »
فيلنيوس، ليتوانيا, April 28, 2025 (GLOBE NEWSWIRE) —
Read more »
VILNIUS, Lithuania, April 25, 2025 (GLOBE NEWSWIRE) — Read more »
Highlights
JERUSALEM, March 28, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, today reported financial results and key business [...] Read more »